InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by EDGEMOND JAMES, Chief Financial Officer. Director active across 1 companies, notably UNITED THERAPEUTICS Corp. Aggregated, 2 disclosures have been recorded. The latest transaction was disclosed on 14 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€1m10,000 shares@ €116.11990.0048% mcap50.0% of flow
Common Stock
SEC:0001636178-26-000018:0·
€1m10,000 shares@ €116.11990.0048% mcap100.0% of flow
Common Stock
SEC:0001636178-26-000018·
2 of 2 declarations
About EDGEMOND JAMES
James Edgemond is the Chief Financial Officer and Treasurer of United Therapeutics Corp. In this role, he is responsible for the company's financial management, including financial planning and risk management. James brings expertise in finance and accounting, contributing to United Therapeutics' performance and growth. His commitment to financial transparency is essential for maintaining investor trust.
